Published on June 20, 2012 at 1:44 AM
Theorem
Clinical Research, a full-service contract research organization
(CRO) providing core clinical research and development services, has
launched its new look and tagline, "Think Theorem."
"The revamped look was designed to further enhance and better
incorporate our vision and mission all while highlighting our services,"
stated Theorem Clinical Research Chief Executive Officer John
Potthoff. "We believe this will effectively communicate the benefits
we provide and position us as the partner of choice for the medical
therapeutic development industry."
Theorem Clinical Research specializes in simplifying complex clinical
trials and provides expertise in biopharmaceutical development, medical
device and diagnostics development, clinical analytics and support in
all risk classifications and approval pathways. The company concentrates
on complex global Phase I-IV clinical trials with therapeutic expertise
in first-in-human, feasibility and combination clinical trials and
pivotal and post-surveillance studies along with all classes of
external, implantable and active-implantable products.
In addition, Theorem Clinical Research offers unmatched access to Asia
because of its experience in conducting one of China's largest outcome
trials. The company has access to investigator sites in more than 30
countries within the Americas, Europe, Middle East and Asia-Pacific.
The new look will be on display June 24-28 in booth #3144 at the Drug
Information Association (DIA) 48th Annual Meeting in
Philadelphia.
Source: Theorem Clinical Research